Seeking Alpha

Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may...

Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may face “widespread” production breakdowns that could take two to three years to correct. Hospira has been working to correct flaws that led to recalls of two drugs in 2009 and 2010, but RBC believes the company’s manufacturing issues are "far greater than investors realize."
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs